VIDEO: Adding docetaxel up front improved survival in prostate cancer by more than a year

CHICAGO –The answer was nearly a decade in coming, but worth the wait: Adding docetaxel to initial hormonal therapy in men with metastatic, hormone-sensitive prostate cancer can extend overall...